BioLabs CEO and leadership

Biotech entrepreneur and investor with a track record of building and growing successful companies. Physician-scientist experienced in the development of complex biologics programs from bench into the clinic, including the first oral RNAi drug to enter the clinic. Co-founder and General Partner at BioInnovation Capital, now MissionBioCapital. Founder/Co-founder of LabCentral, Cambridge Biolabs, BioLabs North Carolina, Philadelphia, San Diego, New York, Princeton, Tufts, Los Angeles; ViThera, Cequent, German Life Science Accelerator.Founding General Partner at Mission BioCapital (fka BioInnovation Capital)Specialties: Company building, Structure of Innovation, Venture Capital, Biologics development, translational science, clinical trials, drug delivery, oligonucleotide therapeutics, startup financing, preclinical and clinical development, technology licensing and development, entrepreneurship, international relations.

Experienced Pharma and not-for-profit leader with a demonstrated history of working to bring new, novel and innovative ideas to fruition . Strong business development professional skilled in Spend Analysis, Analytical Skills, Operational Excellence, Six Sigma, and Quality Assurance.

John is a Certified Public Accountant with the additional designation of Certified Global Management Accountant (CGMA), he has over 20 years of finance experience. His experience in working with small to mid-size companies in many different aspects of accounting and taxation has enabled him to identify and capitalize on global market opportunities to deliver strong and sustained contributions to company visibility, revenue and profits, – throughout all economic cycles. John earned a BS in Accounting from Providence College and an MS in Taxation from Bentley University. John is a member of the American Institute of Certified Public Accountants (AICPA) and the Massachusetts Society of Certified Public Accountants (MSCPA).